West Pharmaceutical Services Inc

Healthcare · Medical Instruments & Supplies

373.60$ -0.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

West Pharmaceutical Services Inc (WST) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 4,076 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet WST
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	1,735	1,717	1,734	1,843	1,930	1,863	1,870	1,874	1,946	1,592	2,036	2,123	2,174	2,341	2,247	2,392	2,583	2,794	2,740	2,934	3,143	3,314	3,295	3,362	3,317	3,617	3,724	3,670	3,755	3,830	3,602	3,489	3,675	3,643	3,618	3,953	4,106	4,270	4,110	4,076
Current Assets	658	642	653	718	777	744	744	767	850	894	868	944	1,004	1,059	978	1,111	1,238	1,374	1,327	1,477	1,598	1,742	1,691	1,771	1,734	1,920	1,937	1,874	1,972	1,936	1,693	1,483	1,551	1,538	1,458	1,681	1,823	1,978	1,827	1,808
Cash	206	203	169	227	269	236	200	226	297	337	266	327	396	439	335	446	519	616	484	576	688	763	668	719	729	894	886	796	899	854	602	446	491	485	404	510	629	791	521	436
Cash & Short-Term Investments	206	203	169	227	269	236	200	226	297	337	266	327	396	439	335	446	519	616	484	576	688	763	668	719	729	894	886	796	899	854	602	446	491	485	404	510	629	791	521	436
Receivables	210	201	225	242	252	253	290	297	303	288	318	331	316	319	333	341	373	385	466	481	476	489	499	528	485	507	513	534	519	512	524	479	524	553	544	582	625	574	686	712
Inventory	201	199	212	211	216	215	216	208	207	215	226	232	230	236	251	275	295	321	310	345	354	378	417	412	413	415	447	449	432	435	430	419	401	377	389	421	438	444	453	447
Property, Plant & Equipment	773	778	783	812	835	855	858	827	822	822	815	823	812	839	828	840	883	943	931	1,036	1,065	1,058	1,066	1,077	1,069	1,158	1,215	1,261	1,408	–	–	–	1,711	1,716	1,767	1,861	1,874	1,843	–	–
Goodwill	105	103	104	106	107	108	109	107	106	106	105	108	107	108	107	108	109	111	110	110	109	110	109	107	104	107	108	108	107	109	108	107	109	106	108	111	111	110	109	109
Intangible Assets	24	23	23	23	23	22	23	22	21	20	20	30	29	30	28	31	31	31	29	28	26	23	22	20	18	18	18	17	16	15	14	13	12	11	10	9.7	8.9	7.7	7.0	6.4
Total Liabilities	593	599	565	601	614	197	198	196	594	583	667	678	686	768	756	786	864	939	911	901	940	978	969	937	846	932	947	923	887	949	922	913	923	961	935	1,024	1,054	1,094	1,119	1,086
Current Liabilities	237	241	257	289	300	280	263	288	289	284	301	313	335	342	344	375	448	503	483	473	559	594	585	565	457	519	535	512	534	672	648	634	517	550	527	605	635	655	674	641
Short-Term Debt	2.6	2.4	34	34	33	103	198	4.4	0.0	0.1	10	10	9.8	12	12	12	12	12	12	12	52	54	54	55	16	18	18	18	72	152	151	153	20	18	22	21	21	23	21	21
Accounts Payable	99	122	106	131	122	138	128	126	125	130	138	152	145	157	158	162	180	213	204	205	208	232	248	220	189	215	234	218	220	242	240	212	224	239	228	239	256	254	252	253
Long-Term Debt	229	226	194	196	197	197	198	196	196	196	196	196	195	255	254	254	253	253	252	252	210	209	208	208	207	207	206	206	152	73	73	73	203	203	203	203	203	203	203	203
Shareholders' Equity	1,142	1,118	1,169	1,242	1,317	1,280	1,305	1,282	1,352	1,396	1,373	1,445	1,488	1,573	1,490	1,606	1,719	1,855	1,829	2,033	2,202	2,335	2,326	2,424	2,471	2,685	2,776	2,747	2,868	2,881	2,681	2,577	2,752	2,682	2,683	2,929	3,052	3,176	2,990	2,990
Retained Earnings	1,042	1,072	1,119	1,148	1,189	1,178	1,223	1,258	1,313	1,353	1,398	1,453	1,497	1,549	1,612	1,703	1,773	1,847	1,985	2,160	2,336	2,457	2,617	2,793	2,913	2,988	3,114	3,255	3,416	3,523	3,624	3,721	3,857	3,957	4,031	4,139	4,262	4,375	4,476	4,624
Shares Outstanding	75	75	75	76	76	76	76	75	76	76	75	75	76	76	76	76	76	76	76	76	76	76	76	76	76	76	76	75	75	75	74	74	73	74	73	73	73	73	72	71

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings